Preliminary Risk Assessment Analysis
Preliminary Risk Assessment analysis helps Regulatory Affairs Leadership and Quality Assurance Leadership evaluate hazard identification coverage, harm traceability, residual risk disposition, and QMS readiness before classification and design-control planning decisions.
What Quality and Regulatory Teams Can Decide From the Analysis
Is hazard coverage clearly defined?
Identify whether Preliminary Risk Assessment defines hazard categories, harm pathways, residual risk boundaries, intended use, and control ownership, so teams can confirm review scope before design-control planning.
Where could traceability gaps appear?
Spot missing harms, weak controls, conflict signals, outdated assumptions, or traceability gaps before they create review delay, approval risk, audit exposure, development rework, or submission risk.
Can teams support earlier classification decisions?
Evaluate whether Preliminary Risk Assessment provides enough hazard evidence, control rationale, and references for Regulatory Affairs, Quality Assurance, and Engineering teams to revise, escalate, or implement with confidence.
How Teams Use This Analysis
Regulatory and quality teams use Preliminary Risk Assessment analysis to review early risk records more consistently, catch hazard coverage gaps earlier, and turn risk narratives into decisions about classification direction and QMS scope.
Validation Documentation Readiness Check
Turns scattered control rationales into structured findings, helping engineering teams prioritize verification needs, residual risk follow-up, and approval decisions.
IEC 62304 Software Lifecycle Scope Assessment
Connects software signals to lifecycle scoping, giving teams a clearer basis for software validation planning and cybersecurity review.
Information Gap Analysis
Organizes open risk questions and review notes into a practical follow-up path, so unresolved issues can be addressed before they become submission delays.
Risk Management Document Review
Maps hazard coverage and harm traceability into a clearer readiness view, helping quality teams understand scoping weaknesses before formal risk file review.
Regulatory Pathway Mapping
Checks whether claims evidence and classification references hold together, reducing the chance that teams rely on unsupported pathway assumptions or outdated reference sources.
Device Risk Profiling
Surfaces severity signals, software dependencies, and misuse scenarios, giving regulatory reviewers earlier visibility into classification pressure before Preliminary Risk Assessment reaches design review.
Key Preliminary Risk Assessment Insights to Look For
Automatan organizes Preliminary Risk Assessment evaluation into structured insights that help teams judge hazard coverage, regulatory alignment, QMS readiness, and the quality of the evidence behind classification decisions.
Document Name
Document title is captured to maintain review traceability and avoid version confusion across early risk assessment cycles.
Device Name
The device name provides a consistent anchor for insights, ensuring the analysis stays linked to the correct medical device concept.
Device Description
A structured summary of clinical function, problem addressed, and workflow role gives teams immediate context without scope misinterpretation.
Device Purpose
Extracted purpose signals distinguish explicit commitments from implied intent, helping teams focus design and regulatory planning where it matters most.
Diagnostic/Therapeutic Decisions
Classification of diagnostic versus therapeutic decisions clarifies which regulatory lens applies and directs early evidence collection.
Life Support
Flags life-support association to highlight elevated regulatory scrutiny and prioritize review efforts.
Invasiveness
Determines invasive or non-invasive status to guide classification assignment and control expectations.
Active Device
Active versus non-active designation informs the correct device framework and classification approach.
Duration of Use
Transient, short-term, or long-term use signals shape biocompatibility classification and monitoring priorities.
Biological Effect
Interaction with biological systems is identified, ensuring contact-based device risks are properly scoped.
Patient Population
Adult, pediatric, geriatric, or mixed population signals provide clarity on intended use scope and regulatory relevance.
Anatomical Location
Automated extraction of anatomical context, such as vascular or dermal location, informs classification and evidence requirements.
Device Class
Directional FDA class signals offer early insight for submission planning.
Device Type
Device category and clinical role anchor classification reasoning and support product family mapping.
Intended User Type
Identifies clinician, patient, or caregiver users to guide usability, labeling, and training considerations.
Intended User Skill Level
Required training signals inform verification planning and human factors study design.
Intended Use Environment
Deployment context, including hospitals, clinics, homes, or emergency settings, ensures use-related risk alignment with actual conditions.
Claims & Clinical Assertions
Automatan compiles safety, performance, clinical, and workflow claims to highlight potential evidence burden.
Regulatory Impact of Claims
Mapping claim implications guides prioritization of supporting documentation and ensures evidence requirements are addressed early.
Device Characteristics
Technical and operational traits, including connectivity, automation, and reuse, affect validation planning and QMS scoping.
Who Uses This Analysis
Preliminary Risk Assessment review pulls in several stakeholders at once. Each group needs a different cut of the same document, focused on the risk, regulatory, quality, and technical questions closest to its mandate.
Regulatory Affairs Leadership
Reads Preliminary Risk Assessment for classification signals, using the analysis to decide whether pre-submission strategy needs adjustment.
Quality Assurance Leadership
Reviews control coverage, helping the team identify QMS scope gaps before design-control planning.
Engineering and Product Teams
Checks software evidence and supporting references, making sure the document can support verification planning.
Human Factors and Usability Teams
Uses the analysis to compare misuse scenarios against design intent, giving stakeholders a clearer basis for formative study planning.
Startup Founders and Executive Teams
Targets optimistic assumptions and follow-up needs, turning the document review into a realistic investment action list.
Investors, Diligence Teams, and Incubators
Assesses the risk-management maturity to determine whether the package supports early-stage diligence decisions.
How Preliminary Risk Assessment Analysis Connects to Your Regulatory Workflow
Automatan works inside the tools regulatory teams already use. Preliminary Risk Assessments and supporting files can be imported from common document sources and turned into structured risk planning intelligence without rebuilding the regulatory process.
Google Drive
Import documents directly from Google Drive so Automatan can extract hazard signals and classification indicators from files already stored by the team.
Add AI Integration
Google Docs
Analyze Preliminary Risk Assessments stored in Google Docs without moving files, enabling seamless extraction of risk intelligence within the existing workspace.
Add AI Integration
OneDrive
Access documents from OneDrive so teams in regulated development environments can capture regulatory signals directly from their repository.
Add AI Integration
Dropbox
Pull risk assessments from Dropbox to turn embedded hazard signals, control measures, and information gaps into structured planning intelligence inside Automatan.
Add AI IntegrationAnalyze Preliminary Risk Assessments With Clearer Risk Evidence
Regulatory and quality teams need more than narrative. Automatan helps teams analyze Preliminary Risk Assessments for classification signals, QMS readiness, and follow-up actions, so every review leads to clearer regulatory decisions.